Literature DB >> 23068609

NOXA contributes to the sensitivity of PERK-deficient cells to ER stress.

Sanjeev Gupta1, Zoltan Giricz, Alessandro Natoni, Neysan Donnelly, Shane Deegan, Eva Szegezdi, Afshin Samali.   

Abstract

PKR-like ER kinase (PERK) deficient mouse embryonic fibroblasts (MEFs) are hypersensitive to ER stress-induced apoptosis. However, the molecular determinants of increased sensitivity of PERK(-/-) MEFs are not clearly understood. Here we show that induction of several Unfolded Protein Response (UPR) target genes is attenuated in PERK(-/-) MEFs. We also report elevated expression of the BH3-only protein, NOXA in PERK(-/-) MEFs. Further, shRNA-mediated knockdown of NOXA rescued the hypersensitivity of PERK(-/-) MEFs to ER stress-induced apoptosis. Taken together our results suggest that compromised induction of UPR and increased NOXA expression contributes to hypersensitivity of PERK(-/-) MEFs to ER stress-induced apoptosis.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23068609     DOI: 10.1016/j.febslet.2012.10.002

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

Review 1.  Endoplasmic reticulum dysfunction in Alzheimer's disease.

Authors:  Jie-Qiong Li; Jin-Tai Yu; Teng Jiang; Lan Tan
Journal:  Mol Neurobiol       Date:  2014-04-09       Impact factor: 5.590

2.  Constitutive High Expression of NOXA Sensitizes Human Embryonic Stem Cells for Rapid Cell Death.

Authors:  Richa Basundra; Sahil Kapoor; Emilie Hollville; Nazanin Kiapour; Adriana Beltran Lopez; Nicole Marie Melchiorre; Mohanish Deshmukh
Journal:  Stem Cells       Date:  2022-03-03       Impact factor: 5.845

Review 3.  Noxa and cancer therapy: Tuning up the mitochondrial death machinery in response to chemotherapy.

Authors:  Marie-Christine Albert; Kerstin Brinkmann; Hamid Kashkar
Journal:  Mol Cell Oncol       Date:  2014-07-28

4.  ERK1/2 signalling protects against apoptosis following endoplasmic reticulum stress but cannot provide long-term protection against BAX/BAK-independent cell death.

Authors:  Nicola J Darling; Kathryn Balmanno; Simon J Cook
Journal:  PLoS One       Date:  2017-09-20       Impact factor: 3.240

5.  PRIMA-1 targets the vulnerability of multiple myeloma of deregulated protein homeostasis through the perturbation of ER stress via p73 demethylation.

Authors:  Phaik Ju Teoh; Chonglei Bi; Chirackal Sintosebastian; Liang Seah Tay; Rafael Fonseca; Wee Joo Chng
Journal:  Oncotarget       Date:  2016-09-20

6.  The Unfolded Protein Response Regulates Uterine Myocyte Antioxidant Responsiveness During Pregnancy.

Authors:  Saiprasad Ramnarayanan; Chandrashekara Kyathanahalli; Judith Ingles; MieJung Park-York; Pancharatnam Jeyasuria; Jennifer C Condon
Journal:  Biol Reprod       Date:  2016-10-12       Impact factor: 4.285

Review 7.  The Best for the Most Important: Maintaining a Pristine Proteome in Stem and Progenitor Cells.

Authors:  Bertal H Aktas; Berin Upcin; Erik Henke; Manju Padmasekar; Xuebin Qin; Süleyman Ergün
Journal:  Stem Cells Int       Date:  2019-05-02       Impact factor: 5.443

8.  Endoplasmic reticulum stress-mediated induction of SESTRIN 2 potentiates cell survival.

Authors:  Svetlana Saveljeva; Patricia Cleary; Katarzyna Mnich; Abiodun Ayo; Karolina Pakos-Zebrucka; John B Patterson; Susan E Logue; Afshin Samali
Journal:  Oncotarget       Date:  2016-03-15

9.  Experimental African trypanosome infection suppresses the development of multiple myeloma in mice by inducing intrinsic apoptosis of malignant plasma cells.

Authors:  Nathan De Beule; Eline Menu; Mathieu J M Bertrand; Mérédis Favreau; Elke De Bruyne; Ken Maes; Kim De Veirman; Magdalena Radwanska; Afshin Samali; Stefan Magez; Karin Vanderkerken; Carl De Trez
Journal:  Oncotarget       Date:  2017-05-24

10.  Hyperactivation of nuclear receptor coactivators induces PERK-dependent cell death.

Authors:  Muhammad Mosaraf Hossain; David Barua; Vahid Arabkari; Nahidul Islam; Ananya Gupta; Sanjeev Gupta
Journal:  Oncotarget       Date:  2018-02-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.